Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00280800Not ApplicableCompleted

Effectiveness of Auto-adjusted Continuous Positive Airway Pressure for Long-term Treatment of Sleep Apnea

Role: collaborator

NCT02268266Not ApplicableCompleted

ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization

Role: collaborator

NCT00719433Phase 2Completed

Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy

Role: collaborator

All 3 trials loaded